- NASDAQ: MRNA shares are set to jump to around $85, a record high.
- Moderna Inc reported progress in its COVID-19 vaccine efforts
- Broader stock markets are also on the rise in the hopes of a broad turnaround.
Moderna Inc. (MRNA) is trading around $87, the highest on record and above the previous peak in May. The company has been at the forefront of efforts to develop immunization for the disease that is gripping the world and is now benefiting from progress as the trial produces a "robust immune response".
MRNA Stock News
The prestigious New England Journal of Medicine reported details about Moderna's vaccine efforts. The Massachusetts-based pharmaceutical firm tested its candidate on 45 humans, which all showed a robust amount of antibodies – as much as four times the level seen in recovered coronavirus patients.
Moreover, side-effects were minimal among those that were tested, showing the vaccine is safe. There still is a long road to approving, producing, and administering a vaccine to the globe's population is still long. Moderna's next step is a broad test of 30,000 people.
Contrary to the previous publication – when Moderna only issued a press release – the publication by the highly regarded magazine is already applauded by the medical community.
It is essential to note that other efforts are in play, most notably cooperation between the University of Oxford and AstraZeneca.
The S/P 500 has turned positive for the year, boosted by the NASDAQ: MRNA news.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
AUD/USD jumps toward 0.6750 after mostly upbeat Aussie jobs data
AUD/USD is picking up fresh toward 0.6750 in Asian trading on Thursday, The pair draws support from mostly upbeat Australian employment data for June, which fan RAB rate hike bets. Meanwhile, the US Dollar remains depressed amid Fed rate cut bets, capping the pair's downside.
USD/JPY drops below 156.00 amid suspected BoJ intervention
The USD/JPY pair attracts some sellers near 155.75 on Thursday during the early Asian trading hours. The pair edges lower on the weaker US Dollar broadly and speculation of the Bank of Japan intervention.
Gold price remains close to record high amid Fed rate cut expectations
Gold price oscillates in a range during the Asian session on Thursday and seems to have stalled a modest retracement slide from a fresh record high touched the previous day. The prevalent risk-on environment acts as a headwind for the XAU/USD. The near-near bias, however, remains tilted in favor of bulls.
Ethereum ETF issuers file updated drafts, ETH staking still a possibility
Ethereum is down 1% on Wednesday as issuers began filing their final spot ETH ETF S-1 drafts with the SEC in anticipation of a launch on July 23. Meanwhile, SEC commissioner Hester Peirce also said the regulator may reconsider its position on ETH staking within the ETFs.
Trump concerned about strong US Dollar
Most of the attention in recent sessions has been around comments from Donald Trump that the US has a big currency problem, and that the stronger US Dollar is hurting the US when it comes to competition with other trading partners.